Factors associated with survival after surgical resection in Chinese patients with ductal adenocarcinoma of the pancreatic head

Digestive Surgery

Volumn 25, Issue 2, 2008, Pages 87-92

  Li, Qiang ^a   Gao, Chuntao ^a   Li, Huikai ^a   Juzi, Jonathan T ^a   Chen, Hua ^a   Hao, Xishan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Oncology; Pancreas surgery; Pancreatic cancer, survival; Pancreatoduodenectomy, prognosis

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHINESE; COHORT ANALYSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RETROPERITONEAL CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TREATMENT OUTCOME;

EID: 44349139473     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121447     Document Type: Article

References (32)

1. Kern S, Hruban R, Hollingsworth MA, et al: A white paper: the product of a pancreas cancer think tank. Cancer Res 2001;61:4923-4932.
2. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358:1576-1585.
3. Mu DQ, Peng SY, Wang GF: Risk factors influencing recurrence following resection of pancreatic head cancer. World J Gastroenterol 2004;10:906-909.
4. Nakao A, Kaneko T, Takeda S, Inoue S, Harada A, Nomoto S, Ekmel T, Yamashita K, Hatsuno T: The role of extended radical operation for pancreatic cancer. Hepatogastroenterology 2001;48:949-952.
5. Sohn TA, Yeo CJ, Cameron JL, et al: Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-579.
6. Richter A, Niedergethmann M, Sturm JW, et al: Long-term results of partial pancreaticoduodenoctomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003;27:324-329.
7. Benassai G, Mastrorilli M, Quarto G, Gappiello A, Giani U, Forestieri P, Mazzeo F: Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 2000;73:212-218.
8. UICC: TNM Classification of Malignant Tumors, ed 6. Berlin, Springer, 2002.
9. Baumel H, Huguier M, Manderscheid JC, et al: Results of resection for cancer of the exocrine pancreas: a study from the French association of surgery. Br J Surg 1994;81:102-107.
10. Sperti C, Pasquali C, Piccoli A, et al: Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625-631.
11. Millikan KW, Deziel DJ, Silverstein JC, et al: Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 1999;65:618-624.
12. Balcom JH IV, Rattner DW, Warshaw AL, et al: Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136: 391-398.
13. Billingsley KG, Hur K, Henderson WG, et al: Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program. J Gastrointest Surg 2003;7:484-491.
14. Crucitti F, Doglietto GB, Viola G, et al: Assessment of risk factors for pancreatic resection for cancer. World J Surg 1998;22:241-247.
15. Yamaguchi K, Mizumoto K, Noshiro H, Sugitani A, et al: Pancreatic carcinoma: < or = 2 cm versus > 2 cm in size. Int Surg 1999;84:213-219.
16. Tomaic A, Pleskovic B, Trotovšek B, et al: Factors influencing survival after duodenopancreatectomy for periampullary adenocarcinoma. Pancreatology 2002;2:217-361.
17. Benassai G, Mastrorilli M, Quarto G, et al: Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 2000;52:263-270.
18. Takamori H, Hiraoka T, Kanemitsu K, et al: Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer. Hepatogastroenterology 2004;51:1500-1503.
19. Takamori H, Hiraoka T, Yamamoto T: Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: clinical and experimental studies. Hepatogastroenterology 1996;43:748-755.
20. Takamori H, Hiraoka T, Kanemitsu K, Tsuji T, Hamada C, Baba H: Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer - underanalysis of cumulative survival curve. World J Surg 2006;30:213-218.
21. Smeenk HG, Tran TCK, Hop WCJ: Analysis of long term survival after R0 resection for pancreatic and periampullary adenocarcinoma. Pancreatology 2003;3:209-269.
22. Capussotti L, Massucco P, Ribero D, et al: Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 2003;138:1316-1322.
23. Meyer W, Jurowich C, Reichel M, et al: Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today 2000;30:582-587.
24. Henne-Bruns D, Vogel I, Luttges J, et al: Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 2000;24:595-602.
25. Yeo CJ, Cameron JL, Lillemoe KD, et al: Pancreaticoduodenectomy for cancer of the head of the pancreas 201 patients. Ann Surg 1995;221:721-733.
26. Takada A, Ohmori K, Takahashi N, et al: Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 1991;179:713-719.
27. Gebhardt C, Meyer W, Reichel M, Wunsch PH: Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg 2000;385:14-20.
28. Sugihara S, Yamamoto T, Tsuruta J, et al: Serine protease induced enhancement of bloodborne metastases of rat ascites tumour cells and its prevention with deoxyribonuclease. Br J Cancer 1990;62:607-613.
29. Van Geenen RC, Keyzer-Dekker CM, Van Tienhoven G, et al: Pain management of patients with unresectable peripancreatic carcinoma. World J Surg 2002;26:715-720.
30. Ni Q, Zhang Q, Cao G, et al: Three steps procedure in the treatment of large pancreatic cancer. Zhonghua Yi Xue Za Zhi 2000;4:252-254.
31. Kalser MH, Ellenberg SS: Pancreatic cancer - adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
32. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010.